vs

Side-by-side financial comparison of Klaviyo, Inc. (KVYO) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Klaviyo, Inc. is the larger business by last-quarter revenue ($350.2M vs $197.9M, roughly 1.8× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs 2.0%, a 4.7% gap on every dollar of revenue. On growth, Klaviyo, Inc. posted the faster year-over-year revenue change (29.6% vs 13.6%). Klaviyo, Inc. produced more free cash flow last quarter ($90.7M vs $17.6M). Over the past eight quarters, Klaviyo, Inc.'s revenue compounded faster (29.1% CAGR vs 14.4%).

Klaviyo is an American technology company that provides a marketing automation platform, used primarily for email marketing and SMS marketing.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

KVYO vs RGEN — Head-to-Head

Bigger by revenue
KVYO
KVYO
1.8× larger
KVYO
$350.2M
$197.9M
RGEN
Growing faster (revenue YoY)
KVYO
KVYO
+16.0% gap
KVYO
29.6%
13.6%
RGEN
Higher net margin
RGEN
RGEN
4.7% more per $
RGEN
6.7%
2.0%
KVYO
More free cash flow
KVYO
KVYO
$73.1M more FCF
KVYO
$90.7M
$17.6M
RGEN
Faster 2-yr revenue CAGR
KVYO
KVYO
Annualised
KVYO
29.1%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KVYO
KVYO
RGEN
RGEN
Revenue
$350.2M
$197.9M
Net Profit
$7.0M
$13.3M
Gross Margin
72.2%
52.5%
Operating Margin
-0.5%
9.0%
Net Margin
2.0%
6.7%
Revenue YoY
29.6%
13.6%
Net Profit YoY
126.1%
143.9%
EPS (diluted)
$0.03
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KVYO
KVYO
RGEN
RGEN
Q4 25
$350.2M
$197.9M
Q3 25
$310.9M
$188.8M
Q2 25
$293.1M
$182.4M
Q1 25
$279.8M
$169.2M
Q4 24
$270.2M
$174.1M
Q3 24
$235.1M
$154.9M
Q2 24
$222.2M
$154.1M
Q1 24
$210.0M
$151.3M
Net Profit
KVYO
KVYO
RGEN
RGEN
Q4 25
$7.0M
$13.3M
Q3 25
$-426.0K
$14.9M
Q2 25
$-24.3M
$14.9M
Q1 25
$-14.1M
$5.8M
Q4 24
$-27.0M
$-30.3M
Q3 24
$-1.3M
$-654.0K
Q2 24
$-4.9M
$3.3M
Q1 24
$-12.9M
$2.1M
Gross Margin
KVYO
KVYO
RGEN
RGEN
Q4 25
72.2%
52.5%
Q3 25
75.5%
53.2%
Q2 25
75.7%
50.0%
Q1 25
75.8%
53.6%
Q4 24
73.4%
26.1%
Q3 24
76.9%
50.0%
Q2 24
77.4%
49.8%
Q1 24
78.6%
49.5%
Operating Margin
KVYO
KVYO
RGEN
RGEN
Q4 25
-0.5%
9.0%
Q3 25
-3.5%
8.9%
Q2 25
-10.7%
7.6%
Q1 25
-8.5%
3.9%
Q4 24
-12.8%
-17.7%
Q3 24
-5.6%
-5.1%
Q2 24
-6.3%
1.0%
Q1 24
-10.5%
1.3%
Net Margin
KVYO
KVYO
RGEN
RGEN
Q4 25
2.0%
6.7%
Q3 25
-0.1%
7.9%
Q2 25
-8.3%
8.2%
Q1 25
-5.0%
3.4%
Q4 24
-10.0%
-17.4%
Q3 24
-0.6%
-0.4%
Q2 24
-2.2%
2.2%
Q1 24
-6.1%
1.4%
EPS (diluted)
KVYO
KVYO
RGEN
RGEN
Q4 25
$0.03
$0.24
Q3 25
$0.00
$0.26
Q2 25
$-0.09
$0.26
Q1 25
$-0.05
$0.10
Q4 24
$-0.09
$-0.55
Q3 24
$-0.01
$-0.01
Q2 24
$-0.02
$0.06
Q1 24
$-0.05
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KVYO
KVYO
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$1.1B
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.2B
$2.1B
Total Assets
$1.6B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KVYO
KVYO
RGEN
RGEN
Q4 25
$1.1B
$767.6M
Q3 25
$980.3M
$748.7M
Q2 25
$935.5M
$708.9M
Q1 25
$888.4M
$697.2M
Q4 24
$881.5M
$757.4M
Q3 24
$826.7M
$784.0M
Q2 24
$793.6M
$809.1M
Q1 24
$755.8M
$780.6M
Total Debt
KVYO
KVYO
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
KVYO
KVYO
RGEN
RGEN
Q4 25
$1.2B
$2.1B
Q3 25
$1.1B
$2.1B
Q2 25
$1.1B
$2.1B
Q1 25
$1.1B
$2.0B
Q4 24
$1.0B
$2.0B
Q3 24
$1.0B
$2.0B
Q2 24
$979.5M
$2.0B
Q1 24
$937.5M
$2.0B
Total Assets
KVYO
KVYO
RGEN
RGEN
Q4 25
$1.6B
$2.9B
Q3 25
$1.5B
$2.9B
Q2 25
$1.4B
$2.9B
Q1 25
$1.3B
$2.9B
Q4 24
$1.3B
$2.8B
Q3 24
$1.2B
$2.8B
Q2 24
$1.1B
$2.9B
Q1 24
$1.1B
$2.8B
Debt / Equity
KVYO
KVYO
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KVYO
KVYO
RGEN
RGEN
Operating Cash FlowLast quarter
$93.2M
$25.7M
Free Cash FlowOCF − Capex
$90.7M
$17.6M
FCF MarginFCF / Revenue
25.9%
8.9%
Capex IntensityCapex / Revenue
0.7%
4.1%
Cash ConversionOCF / Net Profit
13.26×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$208.5M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KVYO
KVYO
RGEN
RGEN
Q4 25
$93.2M
$25.7M
Q3 25
$54.8M
$48.1M
Q2 25
$55.7M
$28.6M
Q1 25
$14.4M
$15.0M
Q4 24
$60.1M
$39.2M
Q3 24
$38.8M
$49.3M
Q2 24
$40.9M
$42.2M
Q1 24
$26.2M
$44.7M
Free Cash Flow
KVYO
KVYO
RGEN
RGEN
Q4 25
$90.7M
$17.6M
Q3 25
$52.5M
$43.4M
Q2 25
$53.7M
$21.5M
Q1 25
$11.7M
$11.4M
Q4 24
$57.7M
$33.6M
Q3 24
$37.2M
$42.3M
Q2 24
$40.1M
$37.4M
Q1 24
$24.9M
$36.4M
FCF Margin
KVYO
KVYO
RGEN
RGEN
Q4 25
25.9%
8.9%
Q3 25
16.9%
23.0%
Q2 25
18.3%
11.8%
Q1 25
4.2%
6.8%
Q4 24
21.4%
19.3%
Q3 24
15.8%
27.3%
Q2 24
18.1%
24.3%
Q1 24
11.9%
24.0%
Capex Intensity
KVYO
KVYO
RGEN
RGEN
Q4 25
0.7%
4.1%
Q3 25
0.7%
2.5%
Q2 25
0.7%
3.9%
Q1 25
1.0%
2.1%
Q4 24
0.9%
3.2%
Q3 24
0.7%
4.5%
Q2 24
0.3%
3.1%
Q1 24
0.6%
5.5%
Cash Conversion
KVYO
KVYO
RGEN
RGEN
Q4 25
13.26×
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons